COLL vs EW · P/E 17, rev $181.9M vs P/E 47, rev $1.39B
Collegium Pharmaceutical Inc (COLL) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the COLL and EW stock pages for the full models.
Not investment advice.